KEZAR LIFE SCIENCES INC's ticker is KZR and the CUSIP is 49372L100. A total of 138 filers reported holding KEZAR LIFE SCIENCES INC in Q1 2023. The put-call ratio across all filers is 0.79 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $34,180 | +44289.6% | 10,920 | 0.0% | 0.02% | -54.3% |
Q4 2022 | $77 | -99.9% | 10,920 | 0.0% | 0.04% | -16.7% |
Q3 2022 | $94,000 | +6.8% | 10,920 | +2.8% | 0.04% | +27.3% |
Q2 2022 | $88,000 | -51.9% | 10,620 | -3.6% | 0.03% | -41.1% |
Q1 2022 | $183,000 | -0.5% | 11,020 | 0.0% | 0.06% | +9.8% |
Q4 2021 | $184,000 | +91.7% | 11,020 | -0.5% | 0.05% | +70.0% |
Q3 2021 | $96,000 | +5.5% | 11,070 | -34.1% | 0.03% | +11.1% |
Q2 2021 | $91,000 | -26.0% | 16,810 | -18.5% | 0.03% | -28.9% |
Q1 2021 | $123,000 | +16.0% | 20,630 | +1.5% | 0.04% | +15.2% |
Q4 2020 | $106,000 | +16.5% | 20,330 | +8.1% | 0.03% | +13.8% |
Q3 2020 | $91,000 | +9.6% | 18,805 | +17.5% | 0.03% | +7.4% |
Q2 2020 | $83,000 | +18.6% | 16,000 | 0.0% | 0.03% | -37.2% |
Q1 2020 | $70,000 | +20.7% | 16,000 | -9.3% | 0.04% | +126.3% |
Q3 2019 | $58,000 | -57.4% | 17,650 | 0.0% | 0.02% | -58.7% |
Q2 2019 | $136,000 | -34.9% | 17,650 | +50.0% | 0.05% | -32.4% |
Q1 2019 | $209,000 | – | 11,764 | – | 0.07% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Prosight Management, LP | 3,200,000 | $10,016,000 | 4.75% |
Qiming U.S. Ventures Management, LLC | 828,711 | $2,593,865 | 3.14% |
SPHERA FUNDS MANAGEMENT LTD. | 1,888,228 | $5,910,154 | 0.99% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 6,887,591 | $21,558,160 | 0.91% |
Avidity Partners Management LP | 6,519,400 | $20,405,722 | 0.68% |
Ikarian Capital, LLC | 841,596 | $2,634,195 | 0.60% |
Opaleye Management Inc. | 625,000 | $1,956,250 | 0.59% |
CHI Advisors LLC | 689,451 | $2,157,982 | 0.57% |
Orbimed Advisors | 5,463,000 | $17,099,190 | 0.34% |
Palo Alto Investors LP | 656,200 | $2,053,906 | 0.17% |